FUMAGALLI, GIULIA
 Distribuzione geografica
Continente #
NA - Nord America 4.805
EU - Europa 2.238
AS - Asia 1.268
OC - Oceania 20
AF - Africa 11
Continente sconosciuto - Info sul continente non disponibili 5
Totale 8.347
Nazione #
US - Stati Uniti d'America 4.733
CN - Cina 518
IT - Italia 464
SE - Svezia 428
DE - Germania 383
SG - Singapore 372
IE - Irlanda 266
RU - Federazione Russa 254
GB - Regno Unito 156
HK - Hong Kong 116
VN - Vietnam 103
UA - Ucraina 73
CA - Canada 69
DK - Danimarca 62
IN - India 43
TR - Turchia 39
FR - Francia 38
AT - Austria 28
KR - Corea 22
FI - Finlandia 20
AU - Australia 19
JP - Giappone 19
BE - Belgio 17
ID - Indonesia 17
EG - Egitto 9
ES - Italia 9
NL - Olanda 7
HR - Croazia 6
CH - Svizzera 5
CZ - Repubblica Ceca 5
EU - Europa 5
IR - Iran 5
RO - Romania 5
TW - Taiwan 5
PT - Portogallo 4
BG - Bulgaria 3
RS - Serbia 3
SA - Arabia Saudita 3
GT - Guatemala 2
SC - Seychelles 2
TH - Thailandia 2
UZ - Uzbekistan 2
KW - Kuwait 1
MY - Malesia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PL - Polonia 1
Totale 8.347
Città #
Ann Arbor 1.897
Wilmington 346
Chandler 323
Singapore 304
Dublin 258
Frankfurt am Main 250
Dearborn 236
Milan 199
Woodbridge 185
Ashburn 147
Houston 145
New York 140
Fairfield 139
Princeton 134
Hong Kong 116
Nanjing 112
Jacksonville 86
Boardman 76
Santa Clara 67
Seattle 65
Guangzhou 55
Nanchang 42
Shanghai 42
Dong Ket 41
Cambridge 37
Lawrence 32
Shenyang 29
Vienna 28
Beijing 27
Altamura 26
Hangzhou 23
Shangdi 21
Jinan 20
Los Angeles 20
Pune 20
Ottawa 19
Toronto 18
Zhengzhou 18
Kunming 17
Sacramento 16
Andover 15
Fremont 15
Sydney 15
Brussels 14
Falls Church 14
Kocaeli 14
Mainz 14
Portland 14
Jakarta 13
Edmonton 12
San Diego 12
Tianjin 12
Changsha 11
Lissone 11
Dallas 10
Norwalk 10
Hebei 9
Jiaxing 9
Lachine 9
Coventry 8
Kiev 8
Yuseong-gu 8
Canazei 7
Chicago 7
Grafing 7
Helsinki 7
Cagliari 6
Codroipo 6
Frederick 6
Hefei 6
London 6
Phoenix 6
Rome 6
Chengdu 5
Induno Olona 5
Merate 5
Montreal 5
Ningbo 5
Pavia 5
Taizhou 5
Takasago 5
Zagreb 5
Brno 4
Cairo 4
Cislago 4
Duncan 4
Falkenstein 4
Fuzhou 4
Laurel 4
Leawood 4
Perugia 4
Tacoma 4
Tokyo 4
Wuhan 4
Absecon 3
Anyang-si 3
Boston 3
Chennai 3
Davie 3
Florence 3
Totale 6.214
Nome #
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 293
The role of Neurofilament Light Chain as a serum biomarker in chemotherapy-induced peripheral neurotoxicity rat models 257
Protective Effect of Human Mesenchymal Stem Cells on the Survival of Pancreatic Islets 253
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 231
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 214
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 203
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 203
Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy 201
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 200
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 195
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 192
Neuroinflammatory Process Involved in Different Preclinical Models of Chemotherapy-Induced Peripheral Neuropathy 190
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 188
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy 182
Study of perpheral neurotoxicity of different doses of oxaliplatin in cd1 mice 180
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 178
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 173
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 173
Sensory-motor paclitaxel polyneuropathy characterization in a rat model 166
Molsidomide provides neuroprotection against vincristine-induced peripheral neurotoxicity 165
ACCURATE NEUROPHYSIOLOGICAL MONITORING FOR SENSORY NEUROPATHY IN MOUSE MODELS OF CHEMOTHERAPY INDUCED PERIPHERAL NEUROTOXICITY 150
EVALUATION OF THE EFFICACY OF PERIPHAGEN NEUROTROPHIN-3 EXPRESSING VECTOR FOR OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY. 148
An in vivo and in vitro neurophysiological approach to acute and chronic oxaliplatin-induced peripheral neurotoxicity 147
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 147
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 147
Intravenous Immunoglobulin Preparation Attenuates Pain Behaviors in a Wistar Rat Model of Bortezomib-Induced Peripheral Neuropathy 136
Topiramate Prevents Oxaliplatin Neurotoxicity in a rat model 134
EMG Recordings at Rest to Verify Axonal Hyperexcitability in a Rat Model of Oxaliplatin Induced Peripheral Neurotoxicity 131
Long-term recovery from chemotherapy-induced neuropathy following paclitaxel, ixabepilone, eribulin and vinorelbine in mice 130
A Possible role of OCT2 gene in the development of peripheral neurotoxicity induced by cisplatin 129
Morphology meets function to unravel Oxaliplatin Induced Peripheral Neurotoxicity (OIPN) 129
How to assess models of oxaliplatin induced peripheral neurotoxicity – a neurophysiological translational approach 128
NERVE EXCITABILITY TESTING AS THE LINK BETWEEN ANATOMY AND PHYSIOLOGY: AXONAL EXCITABILITY TESTING TO TEST IN VIVO MECHANISMS OF PERIPHERAL NERVE DAMAGE. 127
Multimodal experimental approach to the study of human neurological diseases 126
Effect of preventive and therapeutic treatment of ghrelin agonist HM01 on the peripheral neurotoxicity induced by bortezomib in wistar rats. 125
Advanced neurophysiology - a translational approach to neuropathy and neuropathic pain 124
Ghrelin agonist HM01 attenuates chemotherapy-induced neurotoxicity in rodent models 124
The severity of oxaliplatin neurotoxicity is related to differential expression of a solute transporter in mice 123
Tackling Oxaliplatin Induced Peripheral neurotoxicity: from bed to bench side and back. 123
Ivig Effect In A Wistar Rat Model Of Bortezomib-Induced Peripheral Neuropathy 122
Genetic factors influencing the development of vincristine-induced neurotoxicity 120
Oxaliplatin induced peripheral neurotoxicity – a neurophysiological translational approach 118
Addressing the Need of a Translational Approach in Peripheral Neuropathy Research: Morphology Meets Function 116
Blood neurofilament light chains as a potential damage marker in chemotherapy-induce peripheral neuropathy rodent models 115
Pharmacokinetics of IVIg in Wistar rats 113
Macrophage infiltration in different preclinical models of chemotherapy-induced peripheral neurotoxicity 105
7T MRI first exploitation in a chemotherapy induced peripheral neurotoxicity in vivo model. 100
Neurofilament light protein: a blood biomarker of neurodegeneration in chemotherapy-induced peripheral neurotoxicity. 99
Topiramate neuroprotectant effects against oxaliplatin induced peripheral neurotoxicity 97
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain 95
Oxaliplatin induced peripheral neurotoxicity: nerve excitability testing full profile in a long term toxicity animal study 94
In vitro neurotoxicity of new promising metal-based anticancer complexes 93
STANDARD AND ADVANCED NEUROPHYSIOLOGY SET UP IN MOUSE MODELS: SENSORY RECORDINGS AND NERVE EXCITABILITY TESTING OF THE CAUDAL NERVE. 93
Nerve Excitability Testing: An In Vivo Translational Approach To Investigate Oxaliplatin Induced Peripheral Neurotoxicity Pathogenesis And Treatment 91
An innovative traslational approach to oxaliplatin induced peripheral neurotoxicity in animal models: nerve excitability testing. 90
Making connections: gap junctions are pivotal for MSC-induced long lasting survival of sensory neurons 90
Translational approach to chemotherapy induced peripheral neurotoxicity (cipn) – neurophysiology as the link between bench and bed-side 89
Oxaliplatin induced Peripheral Neurotoxicity (OIPN): a Rat Model that full encompasses all OIPN Phenomena 89
Oxaliplatin induced peripheral neurotoxicity (OIPN) and ion unbalance: the perilous link between acute and chronic neurotoxicity. 88
Early stimulation of trek channel transcription and activity induced by oxaliplatin-dependent cytosolic acidification 75
Oxaliplatin induced peripheral neurotoxicity (OIPN): a translational approach for drug discovery. 75
Translating morphology from bench side to bed side via neurophysiology: 8-minute protocol for peripheral neuropathy research 66
TOPIRAMATE PREVENTS OXALIPLATIN ACUTE PERIPHERAL NEUROTOXICITY. 61
Blood NfL as a potential axonal damage marker in different CIPN rat models. 59
The Link between Bench and Bed-Side: “clinical” neurophysiological approach to a rat model of neuropathy 54
Erratum: Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy (Proceedings of the National Academy of Sciences of the United States of America (2021) 118 (e2012685118) DOI: 10.1073/pnas.2012685118) 47
DIFFERENT DEGREES OF MACROPHAGE INFILTRATION IN PRECLINICAL MODELS OF ANTITUBULIN AGENTS-INDUCED PERIPHERAL NEUROTOXICITY 40
Assessment of Neurofilament Light Protein as a Serum Biomarker in Rodent Models of Toxic-Induced Peripheral Neuropathy 29
ENDOCANNABINOID SYSTEM IN BORTEZOMIB NEUROTOXICITY 21
Molsidomine provides neuroprotection against vincristine-induced peripheral neurotoxicity through soluble guanylyl cyclase activation 16
Totale 9.125
Categoria #
all - tutte 28.420
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.420


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.044 0 0 0 71 108 190 214 93 97 155 96 20
2020/20212.104 44 49 215 185 149 216 253 252 189 148 163 241
2021/20221.131 126 166 145 119 88 91 50 45 38 51 72 140
2022/20231.389 163 316 174 120 98 243 21 65 92 26 55 16
2023/20241.002 27 38 30 36 122 235 160 84 61 20 13 176
2024/2025819 139 363 248 69 0 0 0 0 0 0 0 0
Totale 9.125